Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.02.2024 | Case report

Piperacillin/tazobactam

Linear IgA bullous dermatosis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Garcia-Paz V, et al. Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient. Postepy Dermatologii i Alergologii 40: 814-816, No. 6, Dec 2023. Available from: URL: https://dx.doi.org/10.5114/ada.2023.133817 Garcia-Paz V, et al. Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient. Postepy Dermatologii i Alergologii 40: 814-816, No. 6, Dec 2023. Available from: URL: https://​dx.​doi.​org/​10.​5114/​ada.​2023.​133817
Metadaten
Titel
Piperacillin/tazobactam
Linear IgA bullous dermatosis
Publikationsdatum
01.02.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53242-9

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Hydromorphone

Case report

Mepolizumab

Case report

Metronidazole

Case report

Tretinoin

Case report

Multiple drugs